IRINOTECAN AS SALVAGE THERAPY FOR RECURRENT HEPATOBLASTOMA(HB): OUTCOME FROM A TERTIARY CARE CENTRE IN A LOW AND MIDDLE INCOME COUNTRY OVER A 15 YEAR PERIOD
PEDIATRIC BLOOD & CANCER(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined